MBX
MBX Biosciences, Inc.
57.72
+1.39 (+2.47%)
52w low 23.07
72.64 high
69.9% of range
Financial Analysis
| (USD) | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 25.16M | 35.31M | 68.19M | 98.06M | |
| R&D | 21.40M | 28.53M | 57.41M | 79.16M | |
| SG&A | 3.76M | 6.78M | 10.78M | 18.90M | |
| Operating Income | -25.16M | -35.31M | -68.19M | -98.06M | |
| EBITDA | -25.70M | -35.15M | -67.95M | -97.81M | |
| Pretax Income | -26.14M | -32.56M | -61.92M | -86.97M | |
| Net Income | -26.14M | -32.56M | -61.92M | -86.97M | |
| EPS Diluted | -0.82 | -1.02 | -5.82 | -2.38 | |
| Diluted Shares | 31.85M | 31.85M | 10.64M | 36.51M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--